← All presentations

Strategy 7 slides

Why Monthly Sales Tracking Still Leaves Brands in the Dark About the Channel

Discover why looking only at monthly closings hides stockouts and how to anticipate availability risk in the pharma channel.

Why Monthly Sales Tracking Still Leaves Brands in the Dark About the Channel

Discover why looking only at monthly closings hides stockouts and how to anticipate availability risk in the pharma channel.

Contents

  • The Cost of Discovering Stockouts Too Late: Anyone leading commercial operations in the pharmaceutical industry knows the cycle well.
  • The Limit of Traditional Sell-Out Reports: The problem is not the lack of information volume.
  • Separating Demand Fluctuation from Product Absence: A drop in commercialized volume in a pharmacy chain can mean two completely distinct realities.
  • The Recurrent Reading of Signals in the Channel: The way out of this operational blindness is not to create more reports, but to shorten the distance between the channel's signal and the…

The Cost of Discovering Stockouts Too Late

Anyone leading commercial operations in the pharmaceutical industry knows the cycle well. The month closes, consolidated reports arrive on the desk, and the team discovers that sales of an important SKU dropped in a given region.

The Limit of Traditional Sell-Out Reports

The problem is not the lack of information volume. Teams accumulate detailed spreadsheets, chain reports, and extensive dashboards. The hidden premise in much of these tools is that the more historical data the board has, the better the decision will be.

Separating Demand Fluctuation from Product Absence

A drop in commercialized volume in a pharmacy chain can mean two completely distinct realities. It can be the natural retraction of demand for a product in a given period, or it can be an invisible supply problem, where the consumer wants to buy, but finds the shelf empty.

The Recurrent Reading of Signals in the Channel

The way out of this operational blindness is not to create more reports, but to shorten the distance between the channel's signal and the execution priority. When the routine becomes weekly, the team stops chasing losses and starts anticipating where the product is at risk of disappearing.

Where to Look First in the Next Review

Anticipating stock behavior in the pharmaceutical channel requires abandoning the illusion that complex dashboards solve execution problems on their own. Commercial efficiency depends on transforming dispersed signals into clear priorities for the field and trade.

Read the full article →

Turn data into decisions

Dinn shows where pharmacies lack the product, what changed and where to act first, with source and confidence.

Other presentations